Silmitasertib
西他舍替
Report date: 2026/03/20 20:03:07
NME
Base Information
Drug NameSilmitasertib
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[18]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCylene Pharmaceuticals Inc
China Registration ClassN/A
Develop Information
Active CompaniesSenhwa Biosciences, IncThe Milton S. Hershey Medical Center
Inactive CompaniesCylene Pharmaceuticals IncThe University Of Arizona
Active Indications +[10]
Inactive Indications +[8]